Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. (Q38425937)
Jump to navigation
Jump to search
scientific article published on 30 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. |
scientific article published on 30 June 2008 |
Statements
1 reference
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. (English)
1 reference
Amit M Oza
1 reference
Elizabeth A Eisenhauer
1 reference
Laurie Elit
1 reference
Jean-Claude Cutz
1 reference
Akira Sakurada
1 reference
Paul J Hoskins
1 reference
Jim Biagi
1 reference
Prafull Ghatage
1 reference
John Mazurka
1 reference
Diane Provencher
1 reference
Naomi Dore
1 reference
Janet Dancey
1 reference
30 June 2008
1 reference
1 reference
26
1 reference
26
1 reference
4319-4325
1 reference
Identifiers
1 reference
1 reference